Physician profile
Nicholas Skiadas
NPI 1043436140
$3,832.82
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,045 · 2020: $477 · 2021: $831 · 2022: $673 · 2023: $807.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $807.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,170.09 | 2019-2022 | |
| Amgen INC. | $575.82 | 2019-2023 | Repatha |
| Astrazeneca Pharmaceuticals LP | $398.36 | 2019-2023 | Farxiga |
| Boston Scientific Corporation | $393.34 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $282.51 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $195.08 | 2019-2020 | |
| Heartflow, INC. | $159.71 | 2023 | Ffrct |
| Abiomed | $132.77 | 2019-2021 | |
| Cvrx, INC. | $126.82 | 2021 | |
| Lantheus Medical Imaging, INC. | $96.44 | 2020 | |
| Shockwave Medical, INC | $82.42 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $76.50 | 2019-2023 | Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $46.91 | 2019 | |
| Amarin Pharma, INC. | $23.52 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.57 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $16.51 | 2022 | |
| Astellas Pharma US INC | $15.91 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.04 | 2019 | |
| Pfizer INC. | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Skiadas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.